Hypoglycaemic Effects of an Aqueous Leaves Extract of Combretum micranthum in Normoglycaemic Rats

Djike Kouehiouon Justin Anderson-Bel

University Felix Houphouet-Boigny University, Training and Research Unit (UFR) Biosciences, Laboratory of Biology and Health, Abidjan, Côte d’Ivoire.

Zahoui Ouga Stanislas *

University Felix Houphouet-Boigny University, Training and Research Unit (UFR) Biosciences, Laboratory of Biology and Health, Abidjan, Côte d’Ivoire.

Ekra Etchien N’dah Christelle

University Felix Houphouet-Boigny University, Training and Research Unit (UFR) Biosciences, Laboratory of Biology and Health, Abidjan, Côte d’Ivoire.

Nene Bi Semi Anthelme

University Felix Houphouet-Boigny University, Training and Research Unit (UFR) Biosciences, Laboratory of Biology and Health, Abidjan, Côte d’Ivoire.

Flavien Traore

University Felix Houphouet-Boigny University, Training and Research Unit (UFR) Biosciences, Laboratory of Biology and Health, Abidjan, Côte d’Ivoire.

*Author to whom correspondence should be addressed.


Abstract

Background: In order to promote the Ivorian pharmacopoeia, we undertook the study of Combretum micranthum (Combretaceae), a plant commonly used in Ivory Coast for the treatment of diabetes. The aim of this study was to evaluate the hypoglycemic effects of an aqueous leaves extract of Combretum micranthum (EaqCM) in Wistar rats.

Methods and Materials: A phytochemical screening study was performed. The pharmacological test on normoglycaemic rats was carried out in 4 groups of 5 rats per group. Rats in group 1 received 2 ml of distilled water, and rats in the test groups received doses ranging at 100 to 300 mg/kg B.W. of the EAqCM. Tests in pre-treated temporarily hyperglycemic rats were performed in 4 groups of 5 rats per group. The rats in groups 1 and 2 received 2ml of distilled water, the rats in test groups (3 and 4) received the dose of 10-2g/kg B.W. and 100 mg/kg B.W. respectively glibenclamide and EAqCM. Thirty minutes later, all rats except those in group 1 received anhydrous glucose. The protocol for testing post-treated hyperglycaemic rats is the same as that for pretreated rats, except that in this experiment glucose is administered to the animals before the test substances. Blood glucose is measured in the rats at regular intervals of 30, 60, 90, 120, 150, and 180 minutes after administration of the substances.

Results: Qualitative phytochemical analysis of EAqCM revealed the presence of polyphenols, flavonoids, catechic, tannins, quinonic compounds, alkaloids, sterols, and polyterpenes. Pharmacological tests on the glycemia of normoglycemic rats showed that EAqCM has hypoglycemic properties at a dose of 100 mg/kgB.W. with a percentage reduction of 30%. In hyperglycemic rats, EAqCM and glibenclamide exhibited anti-hyperglycemic activity with respective percentages reduction of 57.47 % and 58.82 %.

Conclusion: Antihyperglycemic effect of EAqCM in post-treated rats would probably be due to the presence of polyphenols and flavonoids in this extract. These results support the use of this plant in traditional medicine for the treatment of diabetes.

Keywords: Combretum micranthum, diabetes, hypoglycemic, antihyperglycemic


How to Cite

Anderson-Bel, Djike Kouehiouon Justin, Zahoui Ouga Stanislas, Ekra Etchien N’dah Christelle, Nene Bi Semi Anthelme, and Flavien Traore. 2024. “Hypoglycaemic Effects of an Aqueous Leaves Extract of Combretum Micranthum in Normoglycaemic Rats”. European Journal of Medicinal Plants 35 (3):42-49. https://doi.org/10.9734/ejmp/2024/v35i31190.

Downloads

Download data is not yet available.

References

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res. Clin. Pract. 2019;157:107-843.

World Health Organization (WHO) Global Diabetes Report Cataloguing in Source: WHO Library. 2016;88.

Yao A, Lokrou A, Koffi-Dago P, Kouassi F, Hué A, Danho J, Abodo J. Epidemiological-clinical profile and mortality of diabetics hospitalized in the endocrinology-diabetology department of Yopougon University Hospital, Abidjan, Côte of ivory. Med. Wrong. Metab. 2020; 8(14):754-760.

International Diabetes Federation (IDF). IDF response to the WHO consultation on the Global Action Plan 2013-2020 for the prevention and control of NCDs. Brussels; 2019.

Mangambu MJD, Mushagalusa KF, Kadima NJ. Contribution to the phytochemical study of some antidiabetic medicinal plants from the city of Bukavu and its surroundings (South Kivu, DR Congo). J.Appl. Biosci. 2014;75:6211-6220.

Goh BL, Nanti GG, Zahoui SO, Nene-Bi SA, Traore F. Assessment of the effects of an aqueous extract of the leaves, flowers, and seeds of Crotalaria retusa L (Fabaceae) on the Glycemia in Rats. European Journal of Pharmaceutical Research. 2022, Dec 23;2(3):6-10.

Abo KJC. From plant to molecule: Toxicity, pharmacological effects and mechanism of action of Justicia secunda (Acanthaceae), antihypertensive plant, on the cardiovascular system of mammals. Ph.D. Thesis. Félix Houphouët Boigny University; 2013.

Etame-Loe G, Ebongue OC, Ngaba PG, Ekossono N, Pouka KC, Ngene PJ. Evaluation des activités hypoglycémiante et antihyperglycémiantedes extraits combines au vin de palme des écorces du tronc de Musanga cecropiodes et des fruits de Combretum micranthum chez les rats de la souche albinos Wistar. J. Appl. Biosci. 2018;126:12717- 12723.

Goh Bi La, Toto NK, Zahoui OS, Kassi Y, Nene Bi SA, Traore F. Acute and subacute toxicity assessment of an aqueous extract of Crotalaria retusa (Fabaceae) in Swiss mice and Wistar rats. JDDT. 2021; 11(6):94-100.

Kassi Y, Toto KN, Nanti GGCG, Nene Bi SA, Traoré F. Assessment of the effects of an aqueous trunk bark extract of Parkia biglobosa (mimosaceae) on blood sugar levels in rats. World J. Pharm Pharm Sci. 2018;7:174-186.

Nanti Goore GCG, Nene Bi SA, Touré A, Traore F. Assessment of antioxidant and anti-diabetic activity of Annona sanegalensis and Hallea ledermanni in alloxan-induced diabetic rats. Phol. 2019; 1:319-336.

Serrano XM, Payares G, Mendoza AL. Glibenclamide, a Blocker of KATP Channels, Shows Antileishmanial Activity in Experimental Murine Cutaneous Leishmaniasis. Antimicrob. Ag. Chemother. 2006;50(12):4214–4216.